Previous 10 | Next 10 |
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced its participation in the American Epilepsy Society (AES) 2022 Annual Meeting, taking place December 2-6 in Nashville, Tennessee. The Company’s therapies and technologies will be feature...
Platform simplifies life support, making life-saving technology more accessible to hospitals and critically ill patients LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received 510(k) clearance for extracorporeal m...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced its Chief Executive Officer Damien McDonald will present a general business update during fireside chats at three healthcare conferences in New York this month: Stifel Healthca...
The following slide deck was published by LivaNova PLC in conjunction with their 2022 Q3 earnings call. For further details see: LivaNova PLC 2022 Q3 - Results - Earnings Call Presentation
LivaNova PLC (LIVN) Q3 2022 Results Earnings Conference Call November 2, 2022, 2022, 08:00 AM ET Company Participants Matthew Dodds - Senior Vice President, Corporate Development Damien McDonald - Chief Executive Officer Alex Shvartsburg - Chief Financial Officer...
LivaNova PLC press release ( NASDAQ: LIVN ): Q3 Non-GAAP EPS of $0.58 beats by $0.03 . Revenue of $252.6M (-0.2% Y/Y) beats by $5.81M . FY2022 Outlook : The company continues to expect revenue to grow between 4% and 6% on a constant-currency basis, excludin...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended September 30, 2022. Financial Summary and Highlights 1 Revenue of $252.6 million for the quarter decreased 0.2 percent on a reporte...
Summary LivaNova is clearly doing better in weaker segments and technical profitability has actually been reached now on an operating level. Neuromodulation has been seeing slowing unit growth as seen by signs in our last coverage, but the bigger issue is that its contribution is ...
Summary David Einhorn's 13F stock portfolio value decreased from $1.57B to $1.29B this quarter. Greenlight increased Atlas Air Worldwide, Kyndryl Holdings, and Victoria’s Secret while decreasing Teck Resources, Change Healthcare, Chemours, and International Seaways. They al...
The U.S. Food and Drug Administration (FDA) on Friday classified the recall of several hundred blood bypass pump systems by LivaNova ( NASDAQ: LIVN ) as the most serious type. LivaNova ( LIVN ) in July recalled 484 LifeSPARC Systems in the U.S. distributed between Dec....
News, Short Squeeze, Breakout and More Instantly...
2024-06-23 00:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2024 results on Wednesday, July 31, 2024 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its second-quarter 2024 results prior to the call. ...
2024-06-06 11:00:14 ET Rick Wise from Stifel Nicolaus issued a price target of $70.00 for LIVN on 2024-06-06 09:52:00. The adjusted price target was set to $70.00. At the time of the announcement, LIVN was trading at $53.16. The overall price target consensus is at $69.5...